Aurora Cannabis to Host Fourth Quarter and Fiscal Year 2026 Investor Conference Call and File Related Year End Information

Rhea-AI Summary

Aurora Cannabis (NASDAQ: ACB) will host a fourth quarter and fiscal year 2026 investor conference call on Thursday, June 11, 2026, at 8:00 a.m. Eastern / 6:00 a.m. Mountain. Financial results will be released before market open that same day.

Executive Chairman and CEO Miguel Martin and CFO Simona King will lead the call and Q&A. A webcast link is available via Aurora’s investor relations website under Events.

News Market Reaction – ACB

+5.76%

+5.76% Session close to close

In the May 28 session, ACB gained 5.76%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NASDAQ | TSX: ACB

EDMONTON, AB, May 28, 2026 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, announced today that it has scheduled a conference call to discuss the results for its fourth quarter and fiscal year 2026 on Thursday, June 11, 2026 at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time. The Company will report its financial results for the fourth quarter and fiscal year 2026 before the opening of markets that same day.

Conference Call Details

DATE:	Thursday, June 11, 2026
TIME:	8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time
WEBCAST:	Click Here

Miguel Martin, Executive Chairman and Chief Executive Officer, and Simona King, Chief Financial Officer, will host the conference call and question and answer period. This weblink has also been posted to the Company's "Investor Info" link at https://www.auroramj.com/investors/ under "Events".

About Aurora Cannabis

Aurora is a global leader in medical cannabis, dedicated to improving lives through scientific expertise, proven performance, and a deep commitment to patient care. Aurora serves medical markets across Canada, Europe, Australia, and New Zealand with a portfolio of trusted, leading brands including Aurora®, MedReleaf®, Pedanios®, IndiMed™, San Raf®, and Whistler Medical Marijuana Corporation®. With world-class GMP-certified manufacturing facilities in Canada and Germany, and a team of industry-leading professionals, Aurora continues to expand its global footprint and deliver consistent, high-quality cannabis products with the purpose of Opening the World to Cannabis™. 

Learn more at www.auroramj.com and follow us on X and LinkedIn.

Aurora's common shares trade on the NASDAQ and TSX under the symbol "ACB".

Forward Looking Statements

This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements made in this news release include, but are not limited to, statements regarding the timing for the release of the Company's fourth quarter and fiscal year 2026 financial statements and the conference call to discuss the results.

These forward-looking statements are only predictions. Forward looking information or statements contained in this news release have been developed based on assumptions management considers to be reasonable. Material factors or assumptions involved in developing forward-looking statements include, without limitation, publicly available information from governmental sources as well as from market research and industry analysis and on assumptions based on data and knowledge of this industry which the Company believes to be reasonable. Forward-looking statements are subject to a variety of risks, uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual events, results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking statements. These risks include, but are not limited to, the magnitude and duration of potential new or increased tariffs imposed on goods imported from Canada into the United States; the ability to retain key personnel, the ability to continue investing in infrastructure to support growth, the ability to obtain financing on acceptable terms, the continued quality of our products, customer experience and retention, the development of third party government and non-government consumer sales channels, management's estimates of consumer demand in Canada and in jurisdictions where the Company exports, expectations of future results and expenses, the risk of successful integration of acquired business and operations, management's estimation that SG&A will grow only in proportion of revenue growth, the ability to expand and maintain distribution capabilities, the impact of competition, the general impact of financial market conditions, the yield from cannabis growing operations, product demand, changes in prices of required commodities, competition, and the possibility for changes in laws, rules, and regulations in the industry, epidemics, pandemics or other public health crises and other risks, uncertainties and factors set out under the heading "Risk Factors" in the Company's annual information from dated June 17, 2025  (the "AIF") and filed with Canadian securities regulators available on the Company's issuer profile on SEDAR+ at www.sedarplus.com and filed with and available on the SEC's website at www.sec.gov. The Company cautions that the list of risks, uncertainties and other factors described in the AIF is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law.

View original content to download multimedia:https://www.prnewswire.com/news-releases/aurora-cannabis-to-host-fourth-quarter-and-fiscal-year-2026-investor-conference-call-and-file-related-year-end-information-302783891.html

SOURCE Aurora Cannabis Inc.

FAQ

When is Aurora Cannabis (ACB) Q4 and fiscal year 2026 earnings conference call?

Aurora Cannabis will hold its Q4 and fiscal year 2026 investor conference call on Thursday, June 11, 2026. According to Aurora, the call starts at 8:00 a.m. Eastern Time, 6:00 a.m. Mountain Time, and will follow the same-day earnings release.

What time does the Aurora Cannabis (ACB) Q4 2026 earnings call start?

The Aurora Cannabis Q4 2026 earnings call starts at 8:00 a.m. Eastern Time and 6:00 a.m. Mountain Time. According to Aurora, the financial results for Q4 and fiscal 2026 will be issued before markets open on June 11, 2026.

Who will host the Aurora Cannabis (ACB) Q4 and FY 2026 investor call?

Aurora Cannabis’ Q4 and FY 2026 investor call will be hosted by Miguel Martin and Simona King. According to Aurora, Martin is Executive Chairman and Chief Executive Officer, while King serves as Chief Financial Officer and will join the presentation and Q&A session.

How can investors access the Aurora Cannabis (ACB) June 11, 2026 earnings webcast?

Investors can access the Aurora Cannabis June 11, 2026 earnings webcast through a dedicated online link. According to Aurora, the webcast link is posted on its investor relations website under the “Investor Info” and “Events” sections for convenient access.

When will Aurora Cannabis (ACB) report Q4 and fiscal year 2026 financial results?

Aurora Cannabis will report its Q4 and fiscal year 2026 financial results on Thursday, June 11, 2026. According to Aurora, the company plans to release these results before the opening of markets, ahead of the scheduled investor conference call that morning.